참고문헌
- Barkic M, Crnomarkovic S, Grabusic K, et al (2009). The p53 tumor suppressor causes congenital malformations in Rpl24- deficient mice and promotes their survival. Mol Cell Biol, 29, 2489-504. https://doi.org/10.1128/MCB.01588-08
- Chan YL, Olvera J, Wool IG (1994). The primary structure of rat ribosomal protein L24. Biochem Biophys Res Commun, 202, 1176-80. https://doi.org/10.1006/bbrc.1994.2052
- Chen YT, Feng B, Chen LB (2012). Update of research on drug resistance in small cell lung cancer chemotherapy. Asian Pac J Cancer Prev, 13, 3577-81. https://doi.org/10.7314/APJCP.2012.13.8.3577
- Enooku K, Tateishi R, Kanai F, et al (2012). Evaluation of molecular targeted cancer drug by changes in tumor marker doubling times. J Gastroenterol, 47, 71-8. https://doi.org/10.1007/s00535-011-0462-2
- Haque ME, Elmore KB, Tripathy A, et al (2010). Properties of the C-terminal tail of human mitochondrial inner membrane protein Oxa1L and its interactions with mammalian mitochondrial ribosomes. J Biol Chem, 285, 28353-62. https://doi.org/10.1074/jbc.M110.148262
- Hou X, Peng JX, Hao XY, et al (2013). DNA Methylation Profiling Identifies EYA4 Gene as a Prognostic Molecular Marker in Hepatocellular Carcinoma. Ann Surg Oncol.
- Huang YH, Chen ZK, Huang KT, et al (2013). Decreased expression of LKB1 correlates with poor prognosis in hepatocellular carcinoma patients undergoing hepatectomy. Asian Pac J Cancer Prev, 14, 1985-8. https://doi.org/10.7314/APJCP.2013.14.3.1985
- Kataoka K, Kanazawa A, Iwamoto S, et al (2014). Does "conversion chemotherapy" really improve survival in metastatic colorectal cancer patients with liver-limited disease? World J Surg, 38, 936-46. https://doi.org/10.1007/s00268-013-2305-1
- Kim Y, Kim HD, Youn B, Park YG, Kim J (2013). Ribosomal protein S3 is secreted as a homodimer in cancer cells. Biochem Biophys Res Commun, 441, 805-8. https://doi.org/10.1016/j.bbrc.2013.10.132
- Liu H S, Tan W B, Yang N, et al (2014). Effects of ribosomal protein l39-L on the drug resistance mechanisms of lung cancer A549 cells. Asian Pac J Cancer Prev, 15, 3093-7. https://doi.org/10.7314/APJCP.2014.15.7.3093
- Llovet JM (2014). Liver cancer, Time to evolve trial design after everolimus failure. Nat Rev Clin Oncol, 11, 506-7. https://doi.org/10.1038/nrclinonc.2014.136
- Oishi N, Yamashita T, Kaneko S (2014). Molecular biology of liver cancer stem cells. Liver Cancer, 3, 71-84. https://doi.org/10.1159/000343863
- Ridge CA, McErlean AM, Ginsberg MS (2013). Epidemiology of lung cancer. Semin Intervent Radiol, 30, 93-8. https://doi.org/10.1055/s-0033-1342949
- Sawanyawisuth K, Wongkham C, Araki N, et al (2012). Serial analysis of gene expression reveals promising therapeutic targets for liver fluke-associated cholangiocarcinoma. Asian Pac J Cancer Prev, 13, 89-93.
- Wang H, Hou L, Li A, et al (2014). Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma. Biomed Res Int, 2014, 864894.
- Wang H, Zhao LN, Li KZ, et al (2006). Overexpression of ribosomal protein L15 is associated with cell proliferation in gastric cancer. BMC Cancer, 6, 91. https://doi.org/10.1186/1471-2407-6-91
- Wilson-Edell KA, Kehasse A, Scott GK, et al (2014). RPL24, a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth. Oncotarget, 5, 5165-76.
- Xu HF, Chen L, Liu XD, et al (2014). Targeting EGFL7 expression through RNA interference suppresses renal cell carcinoma growth by inhibiting angiogenesis. Asian Pac J Cancer Prev, 15, 3045-50. https://doi.org/10.7314/APJCP.2014.15.7.3045
피인용 문헌
- Role of uL3 in Multidrug Resistance in p53-Mutated Lung Cancer Cells vol.18, pp.3, 2017, https://doi.org/10.3390/ijms18030547
- Vanadium complex: an appropriate candidate for killing hepatocellular carcinoma cancerous cells pp.1572-8773, 2018, https://doi.org/10.1007/s10534-018-0139-x